Ghassan K. Abou-Alfa, MD, is a member of the Gastrointestinal Oncology Service at Memorial Sloan-Kettering Cancer Center in New York, where he specializes in the treatment of primary liver cancer. Dr. Abou-Alfa received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine. His research is dedicated to finding novel therapies and improving the effectiveness of current therapies for primary liver cancer, while continuing to understand the basic mechanisms of the disease and its therapies. Dr. Abou-Alfa also focuses on the study of prevention of recurrence of primary liver cancer after surgery and has many publications in the field of primary liver cancer. Dr. Abou-Alfa is a strong advocate for raising awareness about liver cancer and has lectured on the subject at universities worldwide. Dr. Eileen M. O’Reilly is an Associate Member of the in the GI Medical Oncology service at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and an Associate Professor of Medicine at Weill Medical College of Cornell University.Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland, where she was born.She completed her residency training in Ireland and Fellowship training at MSKCC and has been a faculty member in the GI Oncology service at MSKCC since that time.Dr. O’Reilly has pancreatic, biliary, neuroendocrine and primary liver cancers as the major focus of her clinical and research activities.Research initiatives include integration of molecular-based therapies for the treatment of pancreas cancer along with development of adjvuant and neoadjuvant therapy.At a national level, Dr. O’Reilly is a member of CALGB’s GI committee and also participates in RTOG and ACOSOG.Dr. O’Reilly’s insitutional administrative commitments include participation in MSKCC’s IRB, Research Council and Clinical Council and Medical Board.Dr. O’Reilly is also the current President of the MSKCC medical staff.